Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions: Results From the Coronary Bifurcation Stenting Registry II [Coronary Interventions]
Conclusions:
The risk of all-cause death or MI was significantly lower in the ≥12-month DAPT group than the <12-month DAPT group after percutaneous coronary intervention for bifurcation lesion using drug-eluting stent. Our results suggest that prolonged DAPT may improve long-term clinical outcomes after percutaneous coronary intervention for bifurcation lesions.
Clinical Trial Registration:
URL: https://www.clinicaltrials.gov. Unique identifier: NCT01642992
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Jang, W. J., Ahn, S. G., Song, Y. B., Choi, S.-H., Chun, W. J., Oh, J. H., Cho, S. W., Kim, B. S., Yoon, J. H., Koo, B.-K., Yu, C. W., Jang, Y. S., Tahk, S.-J., Kim, H.-S., Gwon, H.-C., Lee, S. Y., Hahn, J.-Y. Tags: Percutaneous Coronary Intervention, Stent, Treatment Coronary Interventions Source Type: research
More News: Accidents | Angioplasty | Cardiology | Cardiovascular | Clinical Trials | Coronary Angioplasty | Heart | Heart Attack | Percutaneous Coronary Intervention | Thrombosis